2013 Themed Issue Call for Papers12 September 2011
Rheumatology themed issue 2013CALL FOR PAPERS
What is the significant role of co-morbidities in rheumatic diseases?
Topic: Co-morbidities in rheumatic diseases
• Dr Roy Fleischmann, University of Texas, Southwestern Medical Center; Metroplex Clinical Research Center (MCRC), Walnut Hill Lane, Dallas, USA
• Dr Nicola Goodson, Clinical Sciences Centre, University Hospital Aintree, Longmoor Lane, Liverpool, UK
• Dr Dirk Elewaut, University Hospital Gent, Division of Rheumatology, Gent, Belgium
Continuing our annual themed issues, Rheumatology plans to publish a themed issue is dedicated to co-morbidities in rheumatic diseases.
Why this topic is relevant?
Most patients have co-morbidities that complicate the choice of an effective medication or make the use of an effective drug more difficult. Co-morbidities are a key part of the equation in selecting proper therapy for a patient.
Not all co-morbidities preclude the use of specific medications. The more we learn about the significance of a co-morbidity in a specific disease and how to treat the co-morbidity itself or how to treat around the co-morbidity, the more effective we become as physicians.
Moreover, co-morbidities can affect outcome measures often used when assessing efficacy of an intervention. With the above in mind, we would like to invite submissions on the topics outlined below.
Submissions for topics on:
• The exploration of co-morbidities in rheumatic diseases
• Their impact on the individual with disease
• How the co-morbidity affects the disease process itself
• The choice of appropriate medications to be used when a particular co-morbidity exists
• How the safety of medications should be assessed in the face of a co-morbidity
We invite you to contribute original research or review articles to this upcoming themed issue. When submitting your manuscript online, please mention ‘Themed issue 2013’ in the cover letter and title of the manuscript. All manuscripts should be submitted online at http://mc.manuscriptcentral.com/rheumatology and will undergo peer review as normal (average time to first decision is 22 days). All manuscripts that are unable to meet the revision deadline or require further rounds of revisions will be considered for the normal issue of the Journal. Once accepted, manuscripts will be published online following copyediting and typesetting. Publication in the themed issue WILL NOT DELAY the online publication date of the manuscript. The Journal aims to publish the collective issue in March 2013 but reserves the right to publish the issue at a later date.
Read the free editorial
To read the editorial written by the guest editors that sets out the background for this issue, click here
Deadline for end of submissions: 1 April 2012
Deadline for submission of first revision: 25 April 2012
Expected issue publication date: March 2013
- About this journal
- Rights & Permissions
- Dispatch date of the next issue
- View eLetters
- We are mobile – find out more
- Paediatrics Collection
- Journals Career Network
- British Society for Rheumatology Guidelines
Impact factor: 4.524
5-Yr impact factor: 4.682
Open access options for authors - visit Oxford Open
- This journal enables compliance with the NIH Public Access Policy
- This journal is a member of the Committee on Publication Ethics (COPE)